Programmed cell death (apoptosis) and cancer chemotherapy

Research output: Contribution to journalArticle

Abstract

Background: Programmed cell death involves a genetic reprogramming of the cell to promote an energy-dependent cascade of biochemical and morphological changes within the cell that result in its death and elimination. Methods: The regulations and mechanisms of programmed cell death are reviewed with an emphasis on how derangement of this mechanism may be involved in modulating responsiveness to chemotherapy. Results: Activation of this programmed death process is controlled by a series of endogenous cell-type-specific signals. In addition, a variety of exogenous cell-damaging treatments (eg, radiation, chemicals, and viruses) and most chemotherapeutic drugs can activate this pathway if sufficient injury to the cell occurs. Resistance to chemotherapy can involve alterations in the ability of a malignant cell to activate the programmed cell death (apoptotic) pathway when damaged by these exogenous agents. Conclusion: The most important determinant of tumor resistance may be a generalized resistance to induction of programmed cell death rather than resistance based on specific alteration in drug/target interactions.

Original languageEnglish (US)
Pages (from-to)303-309
Number of pages7
JournalCancer Control
Volume3
Issue number4
StatePublished - 1996

Fingerprint

Cell Death
Apoptosis
Drug Therapy
Neoplasms
Drug Interactions
Radiation
Viruses
Wounds and Injuries
Pharmaceutical Preparations
Therapeutics

ASJC Scopus subject areas

  • Oncology

Cite this

Programmed cell death (apoptosis) and cancer chemotherapy. / Denmeade, Samuel R; Isaacs, John Tod.

In: Cancer Control, Vol. 3, No. 4, 1996, p. 303-309.

Research output: Contribution to journalArticle

@article{e299650d07204cb4b73a37df71968930,
title = "Programmed cell death (apoptosis) and cancer chemotherapy",
abstract = "Background: Programmed cell death involves a genetic reprogramming of the cell to promote an energy-dependent cascade of biochemical and morphological changes within the cell that result in its death and elimination. Methods: The regulations and mechanisms of programmed cell death are reviewed with an emphasis on how derangement of this mechanism may be involved in modulating responsiveness to chemotherapy. Results: Activation of this programmed death process is controlled by a series of endogenous cell-type-specific signals. In addition, a variety of exogenous cell-damaging treatments (eg, radiation, chemicals, and viruses) and most chemotherapeutic drugs can activate this pathway if sufficient injury to the cell occurs. Resistance to chemotherapy can involve alterations in the ability of a malignant cell to activate the programmed cell death (apoptotic) pathway when damaged by these exogenous agents. Conclusion: The most important determinant of tumor resistance may be a generalized resistance to induction of programmed cell death rather than resistance based on specific alteration in drug/target interactions.",
author = "Denmeade, {Samuel R} and Isaacs, {John Tod}",
year = "1996",
language = "English (US)",
volume = "3",
pages = "303--309",
journal = "Cancer Control",
issn = "1073-2748",
publisher = "H. Lee Moffitt Cancer Center and Research Institute",
number = "4",

}

TY - JOUR

T1 - Programmed cell death (apoptosis) and cancer chemotherapy

AU - Denmeade, Samuel R

AU - Isaacs, John Tod

PY - 1996

Y1 - 1996

N2 - Background: Programmed cell death involves a genetic reprogramming of the cell to promote an energy-dependent cascade of biochemical and morphological changes within the cell that result in its death and elimination. Methods: The regulations and mechanisms of programmed cell death are reviewed with an emphasis on how derangement of this mechanism may be involved in modulating responsiveness to chemotherapy. Results: Activation of this programmed death process is controlled by a series of endogenous cell-type-specific signals. In addition, a variety of exogenous cell-damaging treatments (eg, radiation, chemicals, and viruses) and most chemotherapeutic drugs can activate this pathway if sufficient injury to the cell occurs. Resistance to chemotherapy can involve alterations in the ability of a malignant cell to activate the programmed cell death (apoptotic) pathway when damaged by these exogenous agents. Conclusion: The most important determinant of tumor resistance may be a generalized resistance to induction of programmed cell death rather than resistance based on specific alteration in drug/target interactions.

AB - Background: Programmed cell death involves a genetic reprogramming of the cell to promote an energy-dependent cascade of biochemical and morphological changes within the cell that result in its death and elimination. Methods: The regulations and mechanisms of programmed cell death are reviewed with an emphasis on how derangement of this mechanism may be involved in modulating responsiveness to chemotherapy. Results: Activation of this programmed death process is controlled by a series of endogenous cell-type-specific signals. In addition, a variety of exogenous cell-damaging treatments (eg, radiation, chemicals, and viruses) and most chemotherapeutic drugs can activate this pathway if sufficient injury to the cell occurs. Resistance to chemotherapy can involve alterations in the ability of a malignant cell to activate the programmed cell death (apoptotic) pathway when damaged by these exogenous agents. Conclusion: The most important determinant of tumor resistance may be a generalized resistance to induction of programmed cell death rather than resistance based on specific alteration in drug/target interactions.

UR - http://www.scopus.com/inward/record.url?scp=0029743912&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029743912&partnerID=8YFLogxK

M3 - Article

VL - 3

SP - 303

EP - 309

JO - Cancer Control

JF - Cancer Control

SN - 1073-2748

IS - 4

ER -